Frazier Life Sciences

About Frazier Life Sciences

Frazier Life Sciences is a healthcare investment firm dedicated to investing in companies developing novel therapeutics. Their mission is to form partnerships with entrepreneurs to build valuable companies and accelerate the advancement of new therapeutic options for patients, focusing on transformative treatments across all stages of company development.

Products & Services

Venture Funds:Invest primarily in private companies, focusing on company creation (over 30 companies since 2005) and Series A & B rounds, with the latest fund being Frazier Life Sciences XI, a $987 million fund raised in 2022.

Public Funds:Provide capital to small- and mid-cap public biotech companies through financings like follow-ons, CMPOs, PIPEs, IPOs, and open market support, with over $1 billion of committed capital.

Specialties

Novel Therapeutics Company Creation Venture Capital Investments Public Biotech Financing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Fund T: - FT: Venture Fund	A: 1300000000 MR: - FA: $1.3 Billion FAN: 1300000000	D: 2025-07-31 FD: 2025-07-31	-

Venture Fund Latest

2025-07-31

$1.3B

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Albert Cha

Managing Partner

LinkedIn (Pro only)

J

James N. Topper

Managing Partner

P

Patrick Heron

Managing Partner

D

Daniel Estes

General Partner

J

James W. Brush

General Partner and Portfolio Manager

A

Anna H. Chen

Partner

View 71 more team members with Pro

Unlock Full Team Directory

Recent News